Showing results (91-100 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|October 29, 2013
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancersMary L Disis, Yushe Dang, Andrew L Coveler, et al.Cancer Immunology, Immunotherapy : CII|December 24, 2013
Soypeptide lunasin in cytokine immunotherapy for lymphomaHua-Chen Chang, David Lewis, Chun-Yu Tung, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activityM Toledano, C Mathiot, J Michon, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon gamma followed by an analogue (GLA-60) to synthetic lipid A subunitI Saiki, H Maeda, J Murata, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2014
Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesisKatja Hattar, Katharina Franz, Michael Ludwig, et al.Cancer Immunology, Immunotherapy : CII|March 11, 2016
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cellsSusan P Foy, Stefanie J Mandl, Tracy dela Cruz, et al.Cancer Immunology, Immunotherapy : CII|July 4, 2016
Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanomaChristoph Hoeller, Olivier Michielin, Paolo A Ascierto, et al.Cancer Immunology, Immunotherapy : CII|October 3, 2015
Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patientsHiromitsu Araki, Xiaoliang Pang, Nobukazu Komatsu, et al.Cancer Immunology, Immunotherapy : CII|November 7, 2015
Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cellsPhilipp Müller, Sacha I Rothschild, Walter Arnold, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograftG F Rowland, R G Simmonds, V A Gore, et al.Pageof 650